Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa H Butterfield

Showing results (51-60 of 176) with videos related to

Pageof 18
Sort By:
Journal for Immunotherapy of Cancer|June 23, 2016
Phenotypic and functional testing of circulating regulatory T cells in advanced melanoma patients treated with neoadjuvant ipilimumabJanet Retseck, Robert VanderWeele, Hui-Min Lin, et al.
Journal of Translational Medicine|February 23, 2017
Melanoma antigen-specific effector T cell cytokine secretion patterns in patients treated with ipilimumabYana G Najjar, Fei Ding, Yan Lin, et al.
Blood|May 1, 2010
Virally infected and matured human dendritic cells activate natural killer cells via cooperative activity of plasma membrane-bound TNF and IL-15Lazar Vujanovic, David E Szymkowski, Sean Alber, et al.
Journal of Translational Medicine|July 6, 2018
Long term impact of CTLA4 blockade immunotherapy on regulatory and effector immune responses in patients with melanomaJanet Retseck, Alexis Nasr, Yan Lin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2006
Hierarchy of alpha fetoprotein (AFP)-specific T cell responses in subjects with AFP-positive hepatocellular cancerYang Liu, Sean Daley, Viktoria N Evdokimova, et al.
Cancer Immunology Research|April 17, 2019
Tumor-Derived α-Fetoprotein Suppresses Fatty Acid Metabolism and Oxidative Phosphorylation in Dendritic CellsPatricia M Santos, Ashley V Menk, Jian Shi, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 24, 2012
Differing patterns of circulating regulatory T cells and myeloid-derived suppressor cells in metastatic melanoma patients receiving anti-CTLA4 antibody and interferon-α or TLR-9 agonist and GM-CSF with peptide vaccinationAhmad A Tarhini, Lisa H Butterfield, Yongli Shuai, et al.
Journal for Immunotherapy of Cancer|September 18, 2015
Baseline circulating IL-17 predicts toxicity while TGF-β1 and IL-10 are prognostic of relapse in ipilimumab neoadjuvant therapy of melanomaAhmad A Tarhini, Haris Zahoor, Yan Lin, et al.
Journal for Immunotherapy of Cancer|December 6, 2018
SITC 2018 workshop report: Immuno-Oncology Biomarkers: State of the ArtLisa H Butterfield, Mary L Disis, Bernard A Fox, et al.
International Journal of Oncology|April 15, 2011
Lentivirally engineered dendritic cells activate AFP-specific T cells which inhibit hepatocellular carcinoma growth in vitro and in vivoYang Liu, Lisa H Butterfield, Xiaohui Fu, et al.
Pageof 18

Showing results (51-60 of 176) with videos related to

Sort By:
Pageof 18
Journal for Immunotherapy of Cancer|June 23, 2016
Phenotypic and functional testing of circulating regulatory T cells in advanced melanoma patients treated with neoadjuvant ipilimumabJanet Retseck, Robert VanderWeele, Hui-Min Lin, et al.
Journal of Translational Medicine|February 23, 2017
Melanoma antigen-specific effector T cell cytokine secretion patterns in patients treated with ipilimumabYana G Najjar, Fei Ding, Yan Lin, et al.
Blood|May 1, 2010
Virally infected and matured human dendritic cells activate natural killer cells via cooperative activity of plasma membrane-bound TNF and IL-15Lazar Vujanovic, David E Szymkowski, Sean Alber, et al.
Journal of Translational Medicine|July 6, 2018
Long term impact of CTLA4 blockade immunotherapy on regulatory and effector immune responses in patients with melanomaJanet Retseck, Alexis Nasr, Yan Lin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2006
Hierarchy of alpha fetoprotein (AFP)-specific T cell responses in subjects with AFP-positive hepatocellular cancerYang Liu, Sean Daley, Viktoria N Evdokimova, et al.
Cancer Immunology Research|April 17, 2019
Tumor-Derived α-Fetoprotein Suppresses Fatty Acid Metabolism and Oxidative Phosphorylation in Dendritic CellsPatricia M Santos, Ashley V Menk, Jian Shi, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 24, 2012
Differing patterns of circulating regulatory T cells and myeloid-derived suppressor cells in metastatic melanoma patients receiving anti-CTLA4 antibody and interferon-α or TLR-9 agonist and GM-CSF with peptide vaccinationAhmad A Tarhini, Lisa H Butterfield, Yongli Shuai, et al.
Journal for Immunotherapy of Cancer|September 18, 2015
Baseline circulating IL-17 predicts toxicity while TGF-β1 and IL-10 are prognostic of relapse in ipilimumab neoadjuvant therapy of melanomaAhmad A Tarhini, Haris Zahoor, Yan Lin, et al.
Journal for Immunotherapy of Cancer|December 6, 2018
SITC 2018 workshop report: Immuno-Oncology Biomarkers: State of the ArtLisa H Butterfield, Mary L Disis, Bernard A Fox, et al.
International Journal of Oncology|April 15, 2011
Lentivirally engineered dendritic cells activate AFP-specific T cells which inhibit hepatocellular carcinoma growth in vitro and in vivoYang Liu, Lisa H Butterfield, Xiaohui Fu, et al.
Pageof 18